(19)
(11) EP 1 533 618 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
01.02.2006 Bulletin 2006/05

(43) Date of publication:
25.05.2005 Bulletin 2005/21

(21) Application number: 03025338.9

(22) Date of filing: 04.11.2003
(51) International Patent Classification (IPC): 
G01N 33/574(1985.01)
 C12Q 1/68(1980.01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(71) Applicants:
  • Ludwig-Maximilians-Universität München
    80359 München (DE)
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)

    DE 
  • F. HOFFMANN-LA ROCHE AG
    4070 Basel (CH)

    AT BE BG CH CY CZ DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR 

(72) Inventors:
  • Dugas, Martin
    81375 München (DE)
  • Schoch, Claudia
    81477 München (DE)
  • Kohlmann, Alexander
    92318 Neumarkt (DE)
  • Schnittger, Susanne
    81375 ünchen (DE)
  • Kern, Wolfgang
    82319 Starnberg (DE)
  • Haferlach, Torsten
    81477 München (DE)

(74) Representative: Bösl, Raphael Konrad 
Patentanwälte Isenbruck Bösl Hörschler Wichmann Huhn Postfach 860 880
81635 München
81635 München (DE)

   


(54) Method for distinguishing prognostically definable AML


(57) Disclosed is a method for distinguishing prognostically definable AML subtypes with normal karyotype into different prognosis subsets in a sample by determining the expression level of markers, as well as a diagnostic kit and an apparatus containing the markers.